
NRx Pharmaceuticals, Inc.
NRXPHealthcare|Biotechnology|US
$2.38
+0.11 (+4.85%)
DCF Value
$0.70
Cash / Share
$0.71
Ownership Breakdown
86.4%
Float
43.3M
Shares Outstanding
37.4M
Float Shares
Major Holders (9)
Combined: 93.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| B Group Capital LLC | Other | 12.62% | 3,000,000 | Aug 21, 2025 | 13D/G |
| The B Group, Inc. | IA, HC | 12.62% | 3,000,000 | Aug 21, 2025 | 13D/G |
| Branden B. Muhl | HC, IN | 12.62% | 3,000,000 | Aug 21, 2025 | 13D/G |
| Anson Management GP LLC | HC, OO | 9.30% | 1,604,975 | Aug 14, 2025 | 13D/G |
| Moez Kassam | HC, IN | 9.30% | 1,604,975 | Aug 14, 2025 | 13D/G |
| Amin Nathoo | HC, IN | 9.30% | 1,604,975 | Aug 14, 2025 | 13D/G |
| Anson Advisors Inc. | FI, CO | 9.30% | 1,604,975 | Aug 14, 2025 | 13D/G |
| Tony Moore | HC, IN | 9.30% | 1,604,975 | Aug 14, 2025 | 13D/G |
| Anson Funds Management LP | IA, PN | 9.30% | 1,604,975 | Aug 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 445,000 acquired · 168,820 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| ABRAMS MICHAEL S | Chief Financial Officer | Jul 28, 2026 | AWARD | 75,000 | — | — | Form 4 |
| Javitt Jonathan C | director, officer: CEO and Chairman | Jul 28, 2026 | AWARD | 150,000 | — | — | Form 4 |
| Casper Joseph Michael | Chief Operating Officer | Jan 27, 2026 | AWARD | 100,000 | $2.39 | $239.0K | Form 4 |
| Casper Joseph Michael | Chief Operating Officer | Jan 27, 2026 | OTHER | 100,000 | $2.39 | $239.0K | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chairman and Chief Scientist | Apr 9, 2025 | AWARD | 125,000 | $1.73 | $216.2K | Form 4 |
| McBride Dennis | director | Apr 9, 2025 | AWARD | 25,000 | $1.73 | $43.2K | Form 4 |
| Hurvitz Chaim | director | Apr 9, 2025 | AWARD | 25,000 | $1.73 | $43.2K | Form 4 |
| Flynn Patrick John | director | Apr 9, 2025 | AWARD | 50,000 | $1.73 | $86.5K | Form 4 |
| B Group, Inc. | 10 percent owner | Aug 18, 2025 | OTHER | 0 | — | — | Form 4 |
| ABRAMS MICHAEL S | Chief Financial Officer | Feb 7, 2025 | AWARD | 50,000 | $2.94 | $147.0K | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chairman and Chief Scientist | Dec 17, 2024 | BUY | 40,000 | $1.17 | $46.8K | Form 4 |
| ABRAMS MICHAEL S | Nov 18, 2024 | OTHER | 0 | — | — | Form 4 | |
| McBride Dennis | director | Jun 13, 2024 | DISPOSED | 6,320 | $15.30 | $96.7K | Form 4 |
| Rehnquist Janet | director: | Dec 28, 2023 | OTHER | 0 | — | — | Form 4 |
| Narido Richard Clavano | officer | Sep 13, 2023 | OTHER | 0 | — | — | Form 4 |
| Gorovitz Aaron | director | Aug 30, 2023 | BUY | 35,000 | $0.32 | $11.2K | Form 4 |
| Hurvitz Chaim | director | Aug 30, 2023 | BUY | 70,000 | $0.29 | $20.1K | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Scientist | Aug 23, 2023 | BUY | 100,000 | $0.33 | $33.0K | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Scientist | Aug 22, 2023 | BUY | 200,000 | $0.32 | $64.4K | Form 4 |
| Javitt Jonathan C | director, 10 percent owner: | Dec 14, 2022 | GIFT | 300,000 | — | — | Form 4 |
| Javitt Jonathan C | Dec 31, 2022 | OTHER | 0 | — | — | Form 4 | |
| Willard Stephen H | director: CHIEF EXECUTIVE OFFICER | Dec 16, 2022 | BUY | 50,000 | $1.17 | $58.5K | Form 4 |
| VAN VOORHEES SETH | director: CHIEF FINANCIAL OFFICER | Dec 16, 2022 | BUY | 30,000 | $1.10 | $33.0K | Form 4 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Nov 25, 2022 | BUY | 7,021 | $1.11 | $7.8K | Form 4 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Nov 25, 2022 | BUY | 600 | $1.10 | $660.00 | Form 4 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Nov 25, 2022 | BUY | 8,716 | $1.12 | $9.8K | Form 4 |
| Javitt Jonathan C | director | Dec 7, 2022 | SELL | 400,000 | $1.00 | $400.0K | Form 4 |
| Javitt Daniel C. | director | Nov 29, 2022 | SELL | 13,730 | $1.50 | $20.7K | Form 4 |
| Javitt Daniel C. | director | Nov 30, 2022 | SELL | 8,441 | $1.50 | $12.7K | Form 4 |
| Flynn Patrick John | director | Nov 28, 2022 | BUY | 2,500 | $1.24 | $3.1K | Form 4 |
| Flynn Patrick John | director | Nov 28, 2022 | BUY | 2,500 | $1.25 | $3.1K | Form 4 |
| Flynn Patrick John | director | Nov 28, 2022 | BUY | 1,750 | $1.25 | $2.2K | Form 4 |
| VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Nov 25, 2022 | BUY | 7,021 | $1.11 | $7.8K | Form 4 |
| Hurvitz Chaim | director | Nov 18, 2022 | BUY | 40,408 | $1.10 | $44.4K | Form 4 |
| Hurvitz Chaim | director | Nov 17, 2022 | BUY | 171,780 | $1.08 | $185.5K | Form 4 |
| Hurvitz Chaim | director | Nov 16, 2022 | BUY | 287,812 | $0.99 | $284.9K | Form 4 |
| Gorovitz Aaron | director | Oct 21, 2022 | AWARD | 162,660 | — | — | Form 4 |
| Glied Sharon | director | Oct 21, 2022 | AWARD | 162,660 | — | — | Form 4 |
| Flynn Patrick John | director | Oct 21, 2022 | AWARD | 162,660 | — | — | Form 4 |
| Hurvitz Chaim | director | Oct 21, 2022 | AWARD | 162,660 | $0.75 | $122.0K | Form 4 |
| Javitt Daniel C. | director | Nov 16, 2022 | SELL | 133,719 | $1.02 | $136.4K | Form 4 |
| Javitt Daniel C. | director | Nov 17, 2022 | SELL | 33,018 | $1.05 | $34.7K | Form 4 |
| Javitt Daniel C. | director | Nov 11, 2022 | SELL | 49,200 | $1.01 | $49.5K | Form 4 |
| Javitt Daniel C. | director: | Jul 29, 2022 | SELL | 784,063 | $1.01 | $791.4K | Form 4 |
| Willard Stephen H | director, officer: Chief Executive Officer | Jul 12, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Javitt Daniel C. | director: | Jul 1, 2022 | GIFT | 2,000,000 | — | — | Form 4 |
| VAN VOORHEES SETH | Chief Financial Officer | Jun 13, 2024 | DISPOSED | 162,500 | $0.51 | $83.5K | Form 4 |
| Javitt Daniel C. | director: | Jun 3, 2022 | SELL | 115,657 | $0.67 | $76.9K | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Scientist | Jun 1, 2022 | BUY | 100,000 | $0.58 | $58.0K | Form 4 |
| Javitt Jonathan C | Chief Scientist | Jun 1, 2022 | BUY | 100,000 | $58.00 | $5.8M | Form 4 |
| Strassberg Ira S | Chief Financial Officer | Mar 15, 2024 | DISPOSED | 212,500 | $3.10 | $658.8K | Form 4 |
| Besthof Robert | Interim CEO | Mar 8, 2022 | AWARD | 100,000 | $2.61 | $261.0K | Form 4 |
| McMaster Herbert Raymond | director | Aug 26, 2021 | OPTION EX. | 18,300 | $2.22 | $40.6K | Form 4 |
| McMaster Herbert Raymond | director | Aug 26, 2021 | CONVERSION | 28,724 | $2.22 | $63.8K | Form 4 |
| McMaster Herbert Raymond | director | Aug 26, 2021 | AWARD | 10,424 | — | — | Form 4 |
| Javitt Daniel C. | 10 percent owner | Jul 16, 2021 | GIFT | 434,594 | — | — | Form 4 |
| Javitt Daniel C. | 10 percent owner | Jul 16, 2021 | GIFT | 434,594 | — | — | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Aug 19, 2021 | CONVERSION | 43,000 | $3.07 | $132.0K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Sep 2, 2021 | CONVERSION | 28,916 | $3.07 | $88.8K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Aug 19, 2021 | OPTION EX. | 27,395 | $3.07 | $84.1K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Sep 2, 2021 | AWARD | 7,502 | — | — | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Sep 2, 2021 | OPTION EX. | 13,164 | $3.07 | $40.4K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Sep 2, 2021 | CONVERSION | 20,666 | $3.07 | $63.4K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Sep 2, 2021 | AWARD | 10,496 | — | — | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Sep 2, 2021 | OPTION EX. | 18,420 | $3.07 | $56.5K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Aug 19, 2021 | AWARD | 15,605 | — | — | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | Aug 23, 2021 | SELL | 33,715 | $13.11 | $442.0K | Form 4 |
| Besthof Robert | Chief Comm. & Patient Officer | Aug 16, 2021 | CONVERSION | 100,000 | $0.20 | $20.0K | Form 4 |
| Besthof Robert | Chief Comm. & Patient Officer | Aug 16, 2021 | OPTION EX. | 63,710 | $0.20 | $12.7K | Form 4 |
| Besthof Robert | Chief Comm. & Patient Officer | Aug 16, 2021 | AWARD | 36,290 | — | — | Form 4 |
| Besthof Robert | Chief Comm. & Patient Officer | Sep 15, 2021 | SELL | 40,000 | $11.76 | $470.4K | Form 4 |
| McMaster Herbert Raymond | director | May 26, 2021 | DISPOSED | 45,086 | $2.22 | $100.1K | Form 4 |
| McMaster Herbert Raymond | director | May 26, 2022 | DISPOSED | 3,845 | $23.41 | $90.0K | Form 4 |
| Troy Daniel | director | May 24, 2021 | AWARD | 65,437 | $2.18 | $142.7K | Form 4 |
| Troy Daniel | director | May 24, 2021 | AWARD | 43,093 | — | — | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Executive Officer | May 24, 2021 | AWARD | 13,348,997 | — | — | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Executive Officer | May 24, 2021 | AWARD | 1,422,000 | — | — | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Executive Officer | May 24, 2021 | AWARD | 46,332 | — | — | Form 4 |
| Javitt Daniel C. | 10 percent owner | May 24, 2021 | AWARD | 13,971,864 | — | — | Form 4 |
| Hurvitz Chaim | director | May 24, 2021 | AWARD | 1,436,350 | — | — | Form 4 |
| Hurvitz Chaim | director | May 24, 2021 | AWARD | 218,423 | $1.53 | $334.2K | Form 4 |
| Hurvitz Chaim | director | May 24, 2021 | AWARD | 208,443 | — | — | Form 4 |
| Gorovitz Aaron | director | May 24, 2021 | AWARD | 16,678 | — | — | Form 4 |
| Gorovitz Aaron | director | May 24, 2021 | AWARD | 8,336 | — | — | Form 4 |
| Glied Sharon | director | May 24, 2021 | AWARD | 65,437 | $0.21 | $13.7K | Form 4 |
| Glied Sharon | director | May 24, 2021 | AWARD | 13,168 | — | — | Form 4 |
| Fricker William | CFO & Treasurer | May 24, 2021 | AWARD | 99,200 | $3.08 | $305.5K | Form 4 |
| Fricker William | CFO & Treasurer | May 24, 2021 | AWARD | 99,200 | $3.08 | $305.5K | Form 4 |
| Flynn Patrick John | director | May 24, 2021 | AWARD | 692,639 | $3.08 | $2.1M | Form 4 |
| Flynn Patrick John | director | May 24, 2021 | AWARD | 362,332 | — | — | Form 4 |
| Flynn Patrick John | director | May 24, 2021 | AWARD | 35,209 | — | — | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | May 24, 2021 | AWARD | 148,800 | $72.30 | $10.8M | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | May 24, 2021 | AWARD | 143,840 | $3.08 | $443.0K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | May 24, 2021 | AWARD | 49,600 | $3.08 | $152.8K | Form 4 |
| Daigneault Alessandra | General Counsel & Secretary | May 24, 2021 | AWARD | 6,320 | — | — | Form 4 |
| Besthof Robert | Chief Comm. & Patient Officer | May 24, 2021 | AWARD | 347,200 | $0.21 | $72.9K | Form 4 |
| Besthof Robert | Chief Comm. & Patient Officer | May 24, 2021 | AWARD | 347,200 | $3.08 | $1.1M | Form 4 |
| Troy Daniel | director: | May 24, 2021 | OTHER | 0 | — | — | Form 4 |
| Javitt Jonathan C | director, 10 percent owner, officer: Chief Executive Officer | May 24, 2021 | OTHER | 0 | — | — | Form 4 |
| Javitt Daniel C. | 10 percent owner: | May 24, 2021 | OTHER | 0 | — | — | Form 4 |